To issue its 2024 Form 10-Ks early next week on or around March 17. You will find more details there very soon. As indicated in our press release issued last night on the quarter and full year, Ampco's consolidated net sales for the fourth quarter of 2024 were $100.9 million, a decline of 6.6% compared to net sales for the fourth quarter of 2023, due primarily to lower shipment volumes of mill rolls, which could not be offset by the higher shipments in the Air and Liquid Processing segment. For the full year 2024, consolidated debt sales as record Air and Liquid Processing segment sales and higher net pricing in the Forged and Cast Engineered Processing segment nearly offset the decline in mill roll and forged engineered product sales due to weaker market conditions. Non-GAAP adjusted income from operations of $1 million and $8 million for the three and twelve months ended December 31, 2024, respectively, improved from the prior year periods despite lower mill roll demand. This was due to higher roll pricing net of cost changes, which moved surcharges down, as well as improved operational efficiencies, and better manufacturing cost absorption. In terms of GAAP reported results, there were some unusual items affecting comparability, and I'd like to review those now. First, at the end of 2024, we completed an updated revaluation of our long-term asbestos-related liabilities and insurance receivables. The net result of this was a credit recorded in Q4 2024 of $4.1 million, part of which related to lower projected indemnity liability, but most of which related to lower projected defense costs. Both effects changes in the asbestos insurance receivables. This compares to a net charge of $40.9 million for asbestos-related revaluation of indemnity and defense estimates in Q4 of 2023. Again, net of associated asbestos insurance. Another significant item affecting comparability is that in the twelve-month period ended December 31, 2023, we received and recorded $1.9 million for a reimbursement of past energy costs from the local government of one of our foreign subsidiaries. The corporation's total selling and administrative expenses increased in 2024 compared to 2023, primarily due to higher employee-related expense, higher sales commissions expense in Air and Liquid Processing, and due to higher professional fees in corporate. Depreciation and amortization expense rose primarily due to the completion of the U.S. Forged businesses capital equipment modernization program. Interest expense for the three and twelve months ended December 31, 2024, increased in comparison to the same periods of the prior year, primarily due to higher equipment financing debt balance, higher average revolving credit facility borrowings, and higher average interest rates. But it should be noted, however, that the corporation's total debt balance of $128.6 million at December 31, 2024, was flat with the prior year. Other income net for Q4 versus the prior year increased primarily due to favorable changes in foreign exchange, but was about flat for the full year. The income tax provision was higher for the three twelve months ended December 31, 2024, primarily due to the establishment of a valuation allowance on the net deferred tax assets of our UK operations at December 31, 2023, given its three-year cumulative loss history. Due to continued soft cash flow demand. As a result, the income tax provision in 2024 does not include any income tax benefit on the operating losses of the UK. It's also noteworthy that the income tax provision for the three and twelve months ended December 31, 2023, included an approximate $1.3 million benefit associated with the charge for asbestos-related costs last year. Net income attributable to Ampco-Pittsburgh for the three and twelve months ended December 31, 2024, was $3.1 million or $0.16 per common share, and $0.04 and, I'm sorry, and $0.4 million or $0.02 per common share, respectively. For the fourth quarter. Both Q4 and full year include an after-tax impact of the credit for asbestos-related costs of $0.20 per share. This compares to a net loss attributable to Ampco-Pittsburgh of $41.8 million or $2.12 per share and $39.9 million or $2.04 per share, respectively, which include approximately $2 per share and $2.02 per share respectively for the after-tax impact of the charge for asbestos-related costs. Please note that in addition, full-year 2023 EPS benefited by approximately $0.10 per share. Total backlog at December 31, 2024, of $378.9 million was flat with December 31, 2023. Net cash flows provided by operating activities were which compares to a use of $3.7 million for full-year 2023. The primary change factor was a reduction in trade working capital, which was a use in 2023, but a source in 2024. In addition, we had lower outflows for asbestos litigation in 2024. And customer deposits rose in 2024 compared to 2023. Capital expenditures for full-year 2024 ended at $12.2 million and include final capitalization of the U.S. Forged plant modernization CapEx from earlier in the year. However, this does not reflect government grant funding received during 2024 of $3.3 million, which was and will be used to fund CapEx machinery and air and liquid processing. So netting the two brings the number down close to what we had been guiding on previous calls, for 2024 full-year CapEx, net of that grant funding. At December 31, 2024, the corporation's liquidity position included cash on hand of $15.4 million and undrawn availability on our revolving credit facility of $20.6 million. Operator, at this time, we would now like to open the line for questions.